Skip to main content

Advertisement

Log in

ANCA-associated vasculitis in systemic sclerosis report of 3 cases

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

The aim of the study was to describe the occurrence of anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV) in systemic sclerosis (SSc) patients. SSc patients who developed biopsy-proven AAV were identified. Their clinical manifestations, autoantibodies, presentation with vasculitis, treatment and outcome were described and compared with previously reported patients with these two conditions. Of 985 patients, 3 were identified. All patients had interstitial lung disease, and all presented with acute renal failure, proteinuria and hematuria, and were P-ANCA- and anti-Scl-70-positive. One required hemodialysis. Two were hypertensive; additionally, one patient had sinusitis, and another had monoarthritis and a macular rash. All were treated with high-dose corticosteroids and responded to therapy and attained remission at 6 months. At 1 year, one patient died of pneumonia. ANCA-associated vasculitis is a rare but serious finding in SSc patients. Positive anti-Scl-70 antibody is found commonly in these patients. Different treatment modalities are effective. Serious infections can complicate therapy and lead to death.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Bunn CC, Denton CP, Shi-Wen X, Knight C, Black CM (1998) Anti-RNA polymerases and other autoantibody specificities in systemic sclerosis. Br J Rheumatol 37(1):15–20

    Article  PubMed  CAS  Google Scholar 

  2. Steen VD (2005) Autoantibodies in systemic sclerosis. Semin Arthritis Rheum 35(1):35–42

    Article  PubMed  CAS  Google Scholar 

  3. Steen VD (2003) Scleroderma renal crisis. Rheum Dis Clin North Am 29(2):315–333

    Article  PubMed  Google Scholar 

  4. Preliminary criteria for the classification of systemic sclerosis (scleroderma) (1980) Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 23(5):581–590

    Article  Google Scholar 

  5. Oddis CV, Eisenbeis CH Jr, Reidbord HE, Steen VD, Medsger TA Jr (1987) Vasculitis in systemic sclerosis: association with Sjogren’s syndrome and the CREST syndrome variant. J Rheumatol 14(5):942–948

    PubMed  CAS  Google Scholar 

  6. Herrick AL, Oogarah PK, Freemont AJ, Marcuson R, Haeney M, Jayson MI (1994) Vasculitis in patients with systemic sclerosis and severe digital ischaemia requiring amputation. Ann Rheum Dis 53(5):323–326

    Article  PubMed  CAS  Google Scholar 

  7. Choi HK, Merkel PA, Walker AM, Niles JL (2000) Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies. Arthritis Rheum 43(2):405–413

    Article  PubMed  CAS  Google Scholar 

  8. Bonaci-Nikolic B, Nikolic MM, Andrejevic S, Zoric S, Bukilica M (2005) Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides. Arthritis Res Ther 7(5):R1072–R1081

    Article  PubMed  CAS  Google Scholar 

  9. Culver B, Itkin A, Pischel K (2005) Case report and review of minocycline-induced cutaneous polyarteritis nodosa. Arthritis Rheum 53(3):468–470

    Article  PubMed  Google Scholar 

  10. Dobre M, Wish J, Negrea L (2009) Hydralazine-induced ANCA-positive pauci-immune glomerulonephritis: a case report and literature review. Ren Fail 31(8):745–748

    Article  PubMed  CAS  Google Scholar 

  11. Bienaime F, Clerbaux G, Plaisier E, Mougenot B, Ronco P, Rougier JP (2007) D-penicillamine-induced ANCA-associated crescentic glomerulonephritis in Wilson disease. Am J Kidney Dis 50(5):821–825

    Article  PubMed  CAS  Google Scholar 

  12. Nanke Y, Akama H, Terai C, Kamatani N (2000) Rapidly progressive glomerulonephritis with D-penicillamine. Am J Med Sci 320(6):398–402

    Article  PubMed  CAS  Google Scholar 

  13. Hillis GS, Khan IH, Simpson JG, Rees AJ (1997) Scleroderma, D-penicillamine treatment, and progressive renal failure associated with positive antimyeloperoxidase antineutrophil cytoplasmic antibodies. Am J Kidney Dis 30(2):279–281

    Article  PubMed  CAS  Google Scholar 

  14. Karpinski J, Jothy S, Radoux V, Levy M, Baran D (1997) D-penicillamine-induced crescentic glomerulonephritis and antimyeloperoxidase antibodies in a patient with scleroderma. Case report and review of the literature. Am J Nephrol 17(6):528–532

    Article  PubMed  CAS  Google Scholar 

  15. Merkel PA, Polisson RP, Chang Y, Skates SJ, Niles JL (1997) Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease. Ann Intern Med 126(11):866–873

    PubMed  CAS  Google Scholar 

  16. Omote A, Muramatsu M, Sugimoto Y, Hosono S, Murakami R, Tanaka H et al (1997) Myeloperoxidase-specific anti-neutrophil cytoplasmic autoantibodies—related scleroderma renal crisis treated with double-filtration plasmapheresis. Intern Med (Tokyo, Japan) 36(7):508–513

    Article  CAS  Google Scholar 

  17. Anders HJ, Wiebecke B, Haedecke C, Sanden S, Combe C, Schlondorff D (1999) MPO-ANCA-positive crescentic glomerulonephritis: a distinct entity of scleroderma renal disease? Am J Kidney Dis 33(4):e3

    Article  PubMed  CAS  Google Scholar 

  18. Wutzl AL, Foley RN, O’Driscoll BR, Reeve RS, Chisholm R, Herrick AL (2001) Microscopic polyangiitis presenting as pulmonary-renal syndrome in a patient with long-standing diffuse cutaneous systemic sclerosis and antibodies to myeloperoxidase. Arthritis Rheum 45(6):533–536

    Article  PubMed  CAS  Google Scholar 

  19. Endo H, Hosono T, Kondo H (1994) Antineutrophil cytoplasmic autoantibodies in 6 patients with renal failure and systemic sclerosis. J Rheumatol 21(5):864–870

    PubMed  CAS  Google Scholar 

  20. Rho YH, Choi SJ, Lee YH, Ji JD, Song GG (2006) Scleroderma associated with ANCA-associated vasculitis. Rheumatol Int 26(5):369–375

    Article  PubMed  Google Scholar 

  21. Kao L, Weyand C (2010) Vasculitis in systemic sclerosis. Int J Rheumatol :385938

  22. Negi VS, Tripathy NK, Misra R, Nityanand S (1998) Antiendothelial cell antibodies in scleroderma correlate with severe digital ischemia and pulmonary arterial hypertension. J Rheumatol 25(3):462–466

    PubMed  CAS  Google Scholar 

  23. Ihn H, Sato S, Fujimoto M, Igarashi A, Yazawa N, Kubo M et al (2000) Characterization of autoantibodies to endothelial cells in systemic sclerosis (SSc): association with pulmonary fibrosis. Clin Exp Immunol 119(1):203–209

    Article  PubMed  CAS  Google Scholar 

  24. Yu F, Zhao MH, Zhang Y, Zhang YK (2005) Anti-endothelial cell antibodies(AECA) are associated with disease activity of propylthiouracil induced antineutrophil cytoplasmic antibody (ANCA) positive vasculitis. Beijing da xue xue bao Yi xue ban=J Peking Univ 37(4):374–377

    CAS  Google Scholar 

  25. Holmen C, Christensson M, Pettersson E, Bratt J, Stjarne P, Karrar A et al (2004) Wegener’s granulomatosis is associated with organ-specific antiendothelial cell antibodies. Kidney Int 66(3):1049–1060

    Article  PubMed  Google Scholar 

  26. Carvalho D, Savage CO, Isenberg D, Pearson JD (1999) IgG anti-endothelial cell autoantibodies from patients with systemic lupus erythematosus or systemic vasculitis stimulate the release of two endothelial cell-derived mediators, which enhance adhesion molecule expression and leukocyte adhesion in an autocrine manner. Arthritis Rheum 42(4):631–640

    Article  PubMed  CAS  Google Scholar 

  27. Carvalho D, Savage CO, Black CM, Pearson JD (1996) IgG antiendothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro. Induction of adhesion molecule expression and involvement of endothelium-derived cytokines. J Clin Investig 97(1):111–119

    Article  PubMed  CAS  Google Scholar 

  28. Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W et al (2009) EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 68(3):310–317

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Peter Lee.

Additional information

Source of support

Dr. Sindhu Johnson has been awarded a Canadian Institutes of Health Research Clinician Scientist Award and is supported by the Norton-Evans Fund for Scleroderma Research.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Omair, M.A., Mohamed, N., Johnson, S.R. et al. ANCA-associated vasculitis in systemic sclerosis report of 3 cases. Rheumatol Int 33, 139–143 (2013). https://doi.org/10.1007/s00296-011-2359-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-011-2359-z

Keywords

Navigation